Article Details

Moderna Doses First Participants in Early Trial of Seasonal Influenza Vaccine Candidates

Retrieved on: 2022-04-11 16:31:11

Tags for this article:

Click the tags to see associated articles and topics

Moderna Doses First Participants in Early Trial of Seasonal Influenza Vaccine Candidates. View article details on hiswai:

Excerpt

Each vaccine candidate includes 8 mRNAs, which targets both hemagglutinin and neuraminidase at different doses and ratios. Like mRNA-1010, mRNA-1020 ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up